- Report
- January 2026
- 277 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 275 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 384 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 380 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 285 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 390 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 372 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 279 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 278 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 288 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 220 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 380 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 419 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 374 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 485 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 279 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 282 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 372 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 578 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 279 Pages
Global
From €5204EUR$5,850USD£4,515GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more